Skip to main content

Accelerating the commercialisation of a disruptive analytical technology which enables the biopharmaceutical industry to manufacture drugs faster, cheaper and with greater regulatory confidence

Risultati finali

CE marked product

Ensuring that Valitacell product and associated has the required CE registration

Peer reviewed publication submitted

Submission of results and outline of applicability and benefits of technology in a report to be published in a peer reviewed journal or online publication

Results exchanged

Review of the results from the four sites and analysis of same in order to determine the final model to be adopted in the product


High-throughput quantitation of Fc-containing recombinant proteins in cell culture supernatant by fluorescence polarization spectroscopy

Autori: Ben Thompson, Jerry Clifford, Mike Jenns, Andrew Smith, Ray Field, Kalpana Nayyar, David C. James
Pubblicato in: Analytical Biochemistry, 534, 2017, Page(s) 49-55, ISSN 0003-2697
Editore: Academic Press
DOI: 10.1016/j.ab.2017.07.013